The World Market for Diagnostic Reagents and Opacifying Preparations for X-Ray Examinations: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for diagnostic reagents and opacifying preparations for X-ray examinations. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for diagnostic reagents and opacifying preparations for X-ray examinations for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
'Diagnostic reagents and opacifying preparations for X-ray examinations' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'diagnostic reagents and opacifying preparations for X-ray examinations' is 54193.
'Diagnostic reagents and opacifying preparations for X-ray examinations' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'diagnostic reagents and opacifying preparations for X-ray examinations' is 54193.
1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 ALGERIA
3.1.3 KENYA
3.1.4 MOROCCO
3.1.5 SOUTH AFRICA
3.2 ASIA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 NORTH KOREA
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 TAIWAN
3.2.12 THAILAND
3.3 EUROPE: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CROATIA
3.3.6 CYPRUS
3.3.7 DENMARK
3.3.8 FINLAND
3.3.9 FRANCE
3.3.10 GERMANY
3.3.11 GREECE
3.3.12 HUNGARY
3.3.13 IRELAND
3.3.14 ITALY
3.3.15 LATVIA
3.3.16 LITHUANIA
3.3.17 LUXEMBOURG
3.3.18 NORWAY
3.3.19 POLAND
3.3.20 PORTUGAL
3.3.21 ROMANIA
3.3.22 RUSSIA
3.3.23 SLOVAKIA
3.3.24 SLOVENIA
3.3.25 SPAIN
3.3.26 SWEDEN
3.3.27 SWITZERLAND
3.3.28 THE CZECH REPUBLIC
3.3.29 THE NETHERLANDS
3.3.30 THE UNITED KINGDOM
3.3.31 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 CHILE
3.4.5 COLOMBIA
3.4.6 COSTA RICA
3.4.7 MEXICO
3.4.8 PANAMA
3.4.9 PARAGUAY
3.4.10 URUGUAY
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 IRAN
3.7.3 ISRAEL
3.7.4 PAKISTAN
3.7.5 THE UNITED ARAB EMIRATES
3.7.6 TURKEY
4 IMPORTS
4.1 AFRICA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 BENIN
4.1.4 BOTSWANA
4.1.5 BURKINA FASO
4.1.6 CAMEROON
4.1.7 COTE D'IVOIRE
4.1.8 EGYPT
4.1.9 ETHIOPIA
4.1.10 MADAGASCAR
4.1.11 MALAWI
4.1.12 MAURITANIA
4.1.13 MAURITIUS
4.1.14 MOROCCO
4.1.15 MOZAMBIQUE
4.1.16 NIGER
4.1.17 NIGERIA
4.1.18 RWANDA
4.1.19 SENEGAL
4.1.20 SIERRA LEONE
4.1.21 SOUTH AFRICA
4.1.22 TANZANIA
4.1.23 UGANDA
4.1.24 ZIMBABWE
4.2 ASIA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MACAU
4.2.9 MALAYSIA
4.2.10 MONGOLIA
4.2.11 NEPAL
4.2.12 SINGAPORE
4.2.13 SOUTH KOREA
4.2.14 SRI LANKA
4.2.15 TAIWAN
4.2.16 THAILAND
4.2.17 THE PHILIPPINES
4.2.18 VIETNAM
4.3 EUROPE: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BOSNIA AND HERZEGOVINA
4.3.6 BULGARIA
4.3.7 CROATIA
4.3.8 CYPRUS
4.3.9 DENMARK
4.3.10 ESTONIA
4.3.11 FINLAND
4.3.12 FRANCE
4.3.13 GEORGIA
4.3.14 GERMANY
4.3.15 GREECE
4.3.16 HUNGARY
4.3.17 ICELAND
4.3.18 IRELAND
4.3.19 ITALY
4.3.20 KAZAKHSTAN
4.3.21 LATVIA
4.3.22 LITHUANIA
4.3.23 LUXEMBOURG
4.3.24 MACEDONIA
4.3.25 MALTA
4.3.26 MOLDOVA
4.3.27 NORWAY
4.3.28 POLAND
4.3.29 PORTUGAL
4.3.30 ROMANIA
4.3.31 RUSSIA
4.3.32 SLOVAKIA
4.3.33 SLOVENIA
4.3.34 SPAIN
4.3.35 SWEDEN
4.3.36 SWITZERLAND
4.3.37 THE CZECH REPUBLIC
4.3.38 THE NETHERLANDS
4.3.39 THE UNITED KINGDOM
4.3.40 UKRAINE
4.4 LATIN AMERICA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BOLIVIA
4.4.4 BRAZIL
4.4.5 CHILE
4.4.6 COLOMBIA
4.4.7 ECUADOR
4.4.8 EL SALVADOR
4.4.9 GUATEMALA
4.4.10 HONDURAS
4.4.11 MEXICO
4.4.12 NICARAGUA
4.4.13 PANAMA
4.4.14 PARAGUAY
4.4.15 PERU
4.4.16 SURINAME
4.4.17 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 ARUBA
4.5.3 BARBADOS
4.5.4 BERMUDA
4.5.5 CANADA
4.5.6 JAMAICA
4.5.7 THE DOMINICAN REPUBLIC
4.5.8 THE UNITED STATES
4.6 OCEANIA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 FIJI
4.6.4 FRENCH POLYNESIA
4.6.5 NEW CALEDONIA
4.6.6 NEW ZEALAND
4.7 THE MIDDLE EAST: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.7.1 EXECUTIVE SUMMARY
4.7.2 ARMENIA
4.7.3 AZERBAIJAN
4.7.4 BAHRAIN
4.7.5 ISRAEL
4.7.6 JORDAN
4.7.7 KUWAIT
4.7.8 LEBANON
4.7.9 OMAN
4.7.10 PAKISTAN
4.7.11 QATAR
4.7.12 TURKEY
4.7.13 YEMEN
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 ALGERIA
3.1.3 KENYA
3.1.4 MOROCCO
3.1.5 SOUTH AFRICA
3.2 ASIA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 NORTH KOREA
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 TAIWAN
3.2.12 THAILAND
3.3 EUROPE: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CROATIA
3.3.6 CYPRUS
3.3.7 DENMARK
3.3.8 FINLAND
3.3.9 FRANCE
3.3.10 GERMANY
3.3.11 GREECE
3.3.12 HUNGARY
3.3.13 IRELAND
3.3.14 ITALY
3.3.15 LATVIA
3.3.16 LITHUANIA
3.3.17 LUXEMBOURG
3.3.18 NORWAY
3.3.19 POLAND
3.3.20 PORTUGAL
3.3.21 ROMANIA
3.3.22 RUSSIA
3.3.23 SLOVAKIA
3.3.24 SLOVENIA
3.3.25 SPAIN
3.3.26 SWEDEN
3.3.27 SWITZERLAND
3.3.28 THE CZECH REPUBLIC
3.3.29 THE NETHERLANDS
3.3.30 THE UNITED KINGDOM
3.3.31 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 CHILE
3.4.5 COLOMBIA
3.4.6 COSTA RICA
3.4.7 MEXICO
3.4.8 PANAMA
3.4.9 PARAGUAY
3.4.10 URUGUAY
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 IRAN
3.7.3 ISRAEL
3.7.4 PAKISTAN
3.7.5 THE UNITED ARAB EMIRATES
3.7.6 TURKEY
4 IMPORTS
4.1 AFRICA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 BENIN
4.1.4 BOTSWANA
4.1.5 BURKINA FASO
4.1.6 CAMEROON
4.1.7 COTE D'IVOIRE
4.1.8 EGYPT
4.1.9 ETHIOPIA
4.1.10 MADAGASCAR
4.1.11 MALAWI
4.1.12 MAURITANIA
4.1.13 MAURITIUS
4.1.14 MOROCCO
4.1.15 MOZAMBIQUE
4.1.16 NIGER
4.1.17 NIGERIA
4.1.18 RWANDA
4.1.19 SENEGAL
4.1.20 SIERRA LEONE
4.1.21 SOUTH AFRICA
4.1.22 TANZANIA
4.1.23 UGANDA
4.1.24 ZIMBABWE
4.2 ASIA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MACAU
4.2.9 MALAYSIA
4.2.10 MONGOLIA
4.2.11 NEPAL
4.2.12 SINGAPORE
4.2.13 SOUTH KOREA
4.2.14 SRI LANKA
4.2.15 TAIWAN
4.2.16 THAILAND
4.2.17 THE PHILIPPINES
4.2.18 VIETNAM
4.3 EUROPE: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BOSNIA AND HERZEGOVINA
4.3.6 BULGARIA
4.3.7 CROATIA
4.3.8 CYPRUS
4.3.9 DENMARK
4.3.10 ESTONIA
4.3.11 FINLAND
4.3.12 FRANCE
4.3.13 GEORGIA
4.3.14 GERMANY
4.3.15 GREECE
4.3.16 HUNGARY
4.3.17 ICELAND
4.3.18 IRELAND
4.3.19 ITALY
4.3.20 KAZAKHSTAN
4.3.21 LATVIA
4.3.22 LITHUANIA
4.3.23 LUXEMBOURG
4.3.24 MACEDONIA
4.3.25 MALTA
4.3.26 MOLDOVA
4.3.27 NORWAY
4.3.28 POLAND
4.3.29 PORTUGAL
4.3.30 ROMANIA
4.3.31 RUSSIA
4.3.32 SLOVAKIA
4.3.33 SLOVENIA
4.3.34 SPAIN
4.3.35 SWEDEN
4.3.36 SWITZERLAND
4.3.37 THE CZECH REPUBLIC
4.3.38 THE NETHERLANDS
4.3.39 THE UNITED KINGDOM
4.3.40 UKRAINE
4.4 LATIN AMERICA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BOLIVIA
4.4.4 BRAZIL
4.4.5 CHILE
4.4.6 COLOMBIA
4.4.7 ECUADOR
4.4.8 EL SALVADOR
4.4.9 GUATEMALA
4.4.10 HONDURAS
4.4.11 MEXICO
4.4.12 NICARAGUA
4.4.13 PANAMA
4.4.14 PARAGUAY
4.4.15 PERU
4.4.16 SURINAME
4.4.17 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 ARUBA
4.5.3 BARBADOS
4.5.4 BERMUDA
4.5.5 CANADA
4.5.6 JAMAICA
4.5.7 THE DOMINICAN REPUBLIC
4.5.8 THE UNITED STATES
4.6 OCEANIA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 FIJI
4.6.4 FRENCH POLYNESIA
4.6.5 NEW CALEDONIA
4.6.6 NEW ZEALAND
4.7 THE MIDDLE EAST: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
4.7.1 EXECUTIVE SUMMARY
4.7.2 ARMENIA
4.7.3 AZERBAIJAN
4.7.4 BAHRAIN
4.7.5 ISRAEL
4.7.6 JORDAN
4.7.7 KUWAIT
4.7.8 LEBANON
4.7.9 OMAN
4.7.10 PAKISTAN
4.7.11 QATAR
4.7.12 TURKEY
4.7.13 YEMEN
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
